Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients

Transplant Proc. 2000 Sep;32(6):1412-5. doi: 10.1016/s0041-1345(00)01276-8.

Authors

J Hołowiecki¹, M Wojciechowska, S Giebel, M Krawczyk-Kuliś, J Wojnar, L Kachel, D Kata, M Markiewicz

Affiliation

¹ Department of Haematology and Bone Marrow Transplantation, Silesian Medical Academy, Katowice, Poland.

PMID: 10995998
DOI: 10.1016/s0041-1345(00)01276-8

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Adult
Cyclophosphamide / therapeutic use
Drug Therapy, Combination
Epirubicin / therapeutic use*
Etoposide / therapeutic use*
Female
Granulocyte Colony-Stimulating Factor / adverse effects
Granulocyte Colony-Stimulating Factor / therapeutic use*
Hematopoiesis
Hematopoietic Stem Cell Mobilization / methods*
Hematopoietic Stem Cell Transplantation*
Hodgkin Disease / drug therapy
Hodgkin Disease / radiotherapy
Hodgkin Disease / therapy*
Humans
Ifosfamide / therapeutic use*
Lymphoma, Non-Hodgkin / drug therapy
Lymphoma, Non-Hodgkin / radiotherapy
Lymphoma, Non-Hodgkin / therapy*
Male
Middle Aged
Multiple Myeloma / drug therapy
Multiple Myeloma / radiotherapy
Multiple Myeloma / therapy*

Substances

Granulocyte Colony-Stimulating Factor
Epirubicin
Etoposide
Cyclophosphamide
Ifosfamide